Le Lézard
Classified in: Science and technology, Business
Subjects: TNM, PER

Seersite Acquires StreetReader, Appoints Boris Markovich as CEO


NEW YORK, March 6, 2020 /PRNewswire-PRWeb/ -- Seersite announced today that it has acquired StreetReader, the curated communications platform for executives. As part of the transaction, Boris Markovich, founder and CEO of StreetReader, has joined Seersite as CEO.

Rob Pflieger, Chief Investment Officer of Palm Ventures, Seersite's lead investor, stated: "We are excited that Boris has joined Seersite to execute on our vision of becoming the platform for company and market analysis. Seersite is building a unique community which offers a better way to deliver insight and expertise to corporate professionals, investment managers, consultants, and analysts, and StreetReader helps accelerate that strategy."

"Seersite is a new social content platform where users can access news, data, insights, and trends on companies, competitors, and markets they follow," commented Markovich. "I am thrilled to join the Seersite team and build a platform that solves real challenges for the industry. We will soon be opening our platform for select domain experts, research analysts, expert networks, and data providers who are focused on finding new clients and increasing engagement with existing ones. If you fit this profile, I encourage you to request access on seersite.com."

Seersite empowers research analysts, industry experts, and other service providers to share their insights regarding the companies and markets that they follow. These contributors can showcase their expertise, learn from peers, generate client leads, and more effectively execute on their content marketing strategies. As the platform grows, there will be multiple ways for contributors to be compensated and generate new revenue opportunities.

Markovich brings over 20 years of experience to Seersite, and has served in entrepreneurial, general management and leadership roles, including the management of the two largest institutional investment research platforms. Prior to StreetReader, Boris was the Head of Research and Corporate Products at Bloomberg, and GM and Head of Research Products at Thomson Reuters.

About Seersite, LLC
Seersite is the home of shared company and market analysis for investors, analysts, and business leaders. Our community is built on a social content platform where domain experts share their insights in the markets and sectors they follow. Contributors are rewarded in different ways as users discover new ideas, insights and sources on the topics that matter to them. For more information, please visit seersite.com.

Press Contact
Paul Curtis
Seersite, LLC
+1.855.878.6888

 

SOURCE Seersite, LLC


These press releases may also interest you

at 04:26
Allied Market Research has recently published a report, titled, "Aircraft Oxygen System Market Size, Share, Competitive Landscape and Trend Analysis Report by...

at 04:00
Trakx, an emerging global fintech company providing thematic Crypto Tradable Indices ("CTIs"), today announced the launch of the Trakx USDc Earn CTI powered by OpenTrade that is designed to allow users to easily generate high risk-adjusted returns on...

at 04:00
Aiming at offering greater enjoys for customers with products that have less harmful effects on the environment and more benefits on sustainable power generation, Astronergy upgraded its residential products ? ASTRO N7s again with less redundant...

at 04:00
Aetina, a leading Edge AI solution provider, announced the launch of the Aetina IA380E-QUFL at Embedded World 2024 in Nuremberg, Germany. This groundbreaking product is a small form factor PCIe graphics card powered by the high-performance Intel Arc...

at 04:00
A novel ice hockey puck with an integrated chip is revolutionising the world of sport. The Swiss ice hockey puck, known as an "Eisgenoss", which is being issued in a limited edition of gold, silver and conventional hard rubber, marks the beginning of...

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...



News published on and distributed by: